Article info
PDFClinical science
A randomised double-masked trial comparing the visual outcome after treatment with ranibizumab or bevacizumab in patients with neovascular age-related macular degeneration
- Correspondence to Dr Ilse Krebs, Department of Ophthalmology, Rudolf Foundation Clinic, Teaching Hospital of the Medical University Vienna, Juchgasse 25, Vienna 1030, Austria; Ilse.Krebs{at}wienkav.at
Citation
A randomised double-masked trial comparing the visual outcome after treatment with ranibizumab or bevacizumab in patients with neovascular age-related macular degeneration
Publication history
- Received July 20, 2012
- Revised November 8, 2012
- Accepted November 26, 2012
- First published January 3, 2013.
Online issue publication
March 22, 2016
Article Versions
- Previous version (22 March 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions